Clinical Trials Directory

Trials / Completed

CompletedNCT01819285

Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer

Phase III Comparison of Early vs Delayed Endocrine Manipulation (Orchiectomy or LHRH Agonist Therapy) in Previously Untreated Patients With Nonmetastatic Asymptomatic Carcinoma of the Prostate

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
985 (actual)
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC · Network
Sex
Male
Age
80 Years
Healthy volunteers
Not accepted

Summary

Objectives I. Compare, in a randomized Phase III multi-institutional setting, symptom-free survival time of patients with asymptomatic carcinoma of the prostate (T0-4, N0-2, M0) not suited for local curative treatment who are randomly assigned to immediate vs. delayed endocrine intervention (orchiectomy or luteinizing hormone releasing hormone (LHRH) agonist therapy). II. Compare the overall survival of these two groups of patients. III. Compare the time to first evidence of distant progression (N4 or M1) of these two treatment groups. IV. Evaluate the prognostic significance of pretreatment laboratory data and monitor these parameters following endocrine therapy. V. Study the prognosis of various sub-groups of patients stratified according to performance status, local tumor extent, nodal status, and choice of endocrine treatment.

Conditions

Interventions

TypeNameDescription
PROCEDUREImmediate Orchiectomy or depot LHRH
PROCEDUREDelayed Orchiectomy or depot LHRH

Timeline

Start date
1990-02-01
Primary completion
2004-07-01
Completion
2010-09-01
First posted
2013-03-27
Last updated
2013-03-27

Source: ClinicalTrials.gov record NCT01819285. Inclusion in this directory is not an endorsement.